国际医药卫生导报2019，Vol.25Issue(22)：3747-3749,3.DOI:10.3760/cma.j.issn.1007-1245.2019.22.028
阿帕替尼联合鸦胆子注射液治疗晚期恶性肿瘤的临床研究
Clinical study of apatinib combined with brucea javanica injection in the treatment of advanced malignant tumors
摘要
Abstract
Objective To observe the clinical efficacy of apatinib combined with brucea javanica injection in the treatment of advanced malignant tumors.Methods 30 patients with advanced malignant tumors who met the diagnostic criteria were selected.The control group was treated with apatinib alone,and the treatment group was treated with brucea javanica injection on the basis of the control group.The efficacy was evaluated by CHOI standard.KPS score was used to evaluate the quality of life.Results The disease control rate of the treatment group was 70.59％,higher than that of the control group (38.46％);the PFS of the treatment group (6.25 months) was longer than that of the control group (5.46 months) (P＜0.05).Conclusion Brucea javanica injection combined with apatinib in the treatment of advanced malignant tumors can prolong the survival time of patients,improve the quality of life.关键词
鸦胆子/阿帕替尼/恶性肿瘤Key words
Brucea javanica/Apatinib/Malignant tumors引用本文复制引用
段轶茜..阿帕替尼联合鸦胆子注射液治疗晚期恶性肿瘤的临床研究[J].国际医药卫生导报,2019,25(22):3747-3749,3.
